The future of clinical trials innovationMedidata is engaging with regulators to advise on the future of clinical trials, but CEO Tarek Sherif cautions Share XThe future of clinical trials innovationhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-future-of-clinical-trials-innovation/
Why pharma needs honest patient dialogueAstellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the Share XWhy pharma needs honest patient dialoguehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/astellas-pharma-percival-barretto-ko/
The importance of pharma CSRThe industry is increasingly aware of the importance of corporate social responsibility (CSR) programmes – and Alex Kalomparis, Share XThe importance of pharma CSRhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-importance-of-pharma-csr/
Can in vivo imaging deliver the full potential of immunotherapy?In the quest to control cancer we now face the challenge of translating our increasing insights into the Share XCan in vivo imaging deliver the full potential of immunotherapy?https://pharmaphorum.com/views-analysis-oncology/can-in-vivo-imaging-deliver-the-full-potential-of-immunotherapy/
10 tips for successful modern signatoriesThe term “gate-keeper” implies only signatories are concerned with compliance with the ABPI Code of Practice, so we Share X10 tips for successful modern signatorieshttps://pharmaphorum.com/views-analysis-sales-marketing/10-tips-for-successful-modern-signatories/
Making patient involvement meaningfulTrue public and patient involvement in research needs to be more than just a box ticking exercise – Share XMaking patient involvement meaningfulhttps://pharmaphorum.com/views-analysis-patients/making-patient-involvement-meaningful/
Achieving launch excellence in orphan medicinesNew rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking Share XAchieving launch excellence in orphan medicineshttps://pharmaphorum.com/market-access-2/achieving-launch-excellence-in-orphan-medicines/
Why pharma needs to care about global warmingBarely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by Share XWhy pharma needs to care about global warminghttps://pharmaphorum.com/views-and-analysis/why-pharma-needs-to-care-about-global-warming/
As cancer treatments evolve, so must investment mechanismsLast month’s American Society of Clinical Oncology (ASCO) meeting kicked off with a presentation from Professor Ruth Plummer, Share XAs cancer treatments evolve, so must investment mechanismshttps://pharmaphorum.com/views-analysis-oncology/as-cancer-treatments-evolve-so-must-investment-mechanisms/
